A molecular docking study using Tetracycline group of drugs
Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...
Get authentic, real-time news that helps you fight COVID-19 better.
Install PlexusMD App for doctors. It's free.
A molecular docking study using Tetracycline group of drugs and covid protein revealed better binding of covid protein than presently available drugs used for covid. Hence i wrote a proposal to ICMR and many health organisations, authorities all over the world to try or consider use of this medicine before a vaccine is developed. The drug is basically to be used after some one contracts infection and not a prophylactic usage like hydroxychloroquine. Lots of medical literature support this usage though it is an antibacterial drug. It has found to be having anti inflammatory and immune modulatory properties. Some studies have also shown antiviral mechanism too. I will share more information later
Like
Comment
Share